Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 6.64% is 56% above its 5-year average of 4.26%, near the high end of its 5-year range (0.25%–6.64%).
As of the fiscal period ended Tuesday, June 30, 2026. 30.32% above its 12-month average of 5.09%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): 1.45%.
RETURN ON ASSETS (ROA)
6.64%
RETURN ON ASSETS (ROA) AVG TTM
5.09%
RETURN ON ASSETS (ROA) AVG 3Y
3.45%
RETURN ON ASSETS (ROA) AVG 5Y
4.26%
RETURN ON ASSETS (ROA) AVG 10Y
6.45%
RETURN ON ASSETS (ROA) AVG 15Y
5.58%
RETURN ON ASSETS (ROA) AVG 20Y
3.88%
CURRENT VS TTM AVG
+30.32%
CURRENT VS 3Y AVG
+92.46%
CURRENT VS 5Y AVG
+55.99%
CURRENT VS 10Y AVG
+2.99%
CURRENT VS 15Y AVG
+18.96%
CURRENT VS 20Y AVG
+70.95%
SECTOR MEDIAN · HEALTHCARE
-30.70%
median of 731 covered companies
CURRENT VS SECTOR MEDIAN
+121.63%
vs the sector median at left
Phibro Animal Health Corporation
Market Cap
$1.50B
Return on Assets (ROA)
6.64%
TTM Avg
5.09%
3Y Avg
3.45%
5Y Avg
4.26%
Market Cap
$1.50B
Return on Assets (ROA)
10.96%
TTM Avg
-5.00%
3Y Avg
-12.25%
5Y Avg
-27.07%
Market Cap
$1.49B
Return on Assets (ROA)
-29.88%
TTM Avg
-23.31%
3Y Avg
-25.68%
5Y Avg
-25.68%
Market Cap
$1.48B
Return on Assets (ROA)
-16.72%
TTM Avg
-18.71%
3Y Avg
-15.50%
5Y Avg
-12.14%
Market Cap
$1.46B
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.55B
Return on Assets (ROA)
-25.60%
TTM Avg
-33.58%
3Y Avg
-30.56%
5Y Avg
-19.71%
Market Cap
$1.54B
Return on Assets (ROA)
18.65%
TTM Avg
7.83%
3Y Avg
-23.56%
5Y Avg
-4.38%
Market Cap
$1.46B
Return on Assets (ROA)
-4.89%
TTM Avg
-0.43%
3Y Avg
-0.87%
5Y Avg
-1.37%
Market Cap
$1.46B
Return on Assets (ROA)
14.98%
TTM Avg
6.07%
3Y Avg
5.42%
5Y Avg
6.72%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phibro Animal Health Corporation (PAHC) | $1.50B | 6.64% | 5.09% | 3.45% | 4.26% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 10.96% | -5.00% | -12.25% | -27.07% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.49B | -29.88% | -23.31% | -25.68% | -25.68% |
| GH Research PLC (GHRS)vs › | $1.48B | -16.72% | -18.71% | -15.50% | -12.14% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.46B | N/A | N/A | N/A | N/A |
| uniQure N.V. (QURE)vs › | $1.55B | -25.60% | -33.58% | -30.56% | -19.71% |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 18.65% | 7.83% | -23.56% | -4.38% |
| Certara, Inc. (CERT)vs › | $1.46B | -4.89% | -0.43% | -0.87% | -1.37% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 14.98% | 6.07% | 5.42% | 6.72% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 20.98% | 9.19% | 12.55% | 16.89% |
ROA
6.6%
ROE
25.9%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | 6.64% |
| 2025-06-30 | 3.55% |
| 2024-06-30 | 0.25% |
| 2023-06-30 | 3.36% |
| 2022-06-30 | 5.28% |
| 2021-06-30 | 6.46% |
| 2020-06-30 | 4.28% |
| 2019-06-30 | 7.53% |
| 2018-06-30 | 9.66% |
| 2017-06-30 | 10.36% |
| 2016-06-30 | 13.55% |
| 2015-06-30 | 12.22% |
| 2014-06-30 | -0.66% |
| 2013-06-30 | 5.25% |
| 2012-06-30 | 1.58% |
| 2011-06-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-06-30 | -2.46% |
| 2006-06-30 | -5.28% |
| 2005-06-30 | -8.73% |
| 2004-06-30 | 5.34% |
| 2003-06-30 | -6.42% |
| 2002-06-30 | -17.48% |
| 2001-06-30 | -4.52% |
| 2000-06-30 | 3.91% |
